Moreover, the high expression of PBX1 was shown to be closely associated with poor prognosis in patients with the oestrogen receptor (ER)‐positive (p = 0.021), luminal A (p = 0.026) and luminal B (p = 0.0012) subtypes of BC.109. This evidence concerns the gene PBX1 and breast cancer.